Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label randomized and controlled clinical trial among multibacillary patients

摘要

BackgroundLeprosy control is based on early diagnosis and multidrug therapy. For treatment purposes, leprosy patients can be classified as paucibacillary (PB) or multibacillary (MB), according to the number of skin lesions. Studies regarding a uniform treatment regimen (U-MDT) for all leprosy patients have been encouraged by the WHO, rendering disease classification unnecessary.